THE COLDAI TIMES
Artificial Intelligence
ByteDance Spins Out Anew Labs in $290 Million AI Drug Bet
ByteDance’s drug-discovery arm raises $290 million at a $1.5 billion valuation, signaling that AI biotech is separating from consumer tech.
·3 min read